Janus Henderson Group PLC Decreases Position in The Cooper Companies, Inc. $COO

Janus Henderson Group PLC cut its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,067,125 shares of the medical device company’s stock after selling 39,280 shares during the quarter. Janus Henderson Group PLC’s holdings in Cooper Companies were worth $219,299,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Root Financial Partners LLC increased its stake in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. SJS Investment Consulting Inc. boosted its holdings in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the 2nd quarter worth approximately $36,000. Cromwell Holdings LLC raised its holdings in Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares during the period. Finally, MUFG Securities EMEA plc purchased a new stake in Cooper Companies in the 2nd quarter worth about $42,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on COO shares. Needham & Company LLC decreased their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Mizuho set a $85.00 target price on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird reduced their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. Finally, Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and an average price target of $81.36.

Cooper Companies Stock Down 0.6%

NASDAQ:COO opened at $72.65 on Friday. The firm’s 50 day simple moving average is $68.17 and its 200 day simple moving average is $71.79. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a market cap of $14.17 billion, a PE ratio of 61.57, a P/E/G ratio of 1.91 and a beta of 0.84. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.